Status:
COMPLETED
Metformin in Psoriatic Arthritis
Lead Sponsor:
University of Alexandria
Conditions:
Psoriatic Arthritis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Psoriatic arthritis (PsA) is a systemic, inflammatory disease. The chronic inflammation in PsA predisposes patients to the metabolic syndrome (MetS). MetS is associated with systemic inflammation and ...
Detailed Description
The chronic inflammatory nature of psoriasis and PsA predisposes patients to cardiovascular diseases and metabolic syndrome (MetS). MetS is associated with systemic inflammation and proinflammatory cy...
Eligibility Criteria
Inclusion
- Psoriatic arthritis patients
Exclusion
- other inflammatory conditions
Key Trial Info
Start Date :
September 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT02188654
Start Date
September 1 2013
End Date
April 1 2014
Last Update
July 11 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alexandria
Alexandria, Alexandria Governorate, Egypt, 00203